Transfusion Medicine and Hemotherapy - in PubMed - Karger Publishers
←
→
Transkription von Seiteninhalten
Wenn Ihr Browser die Seite nicht korrekt rendert, bitte, lesen Sie den Inhalt der Seite unten
47 | 2 | 20
Oncology
Transfusion Medicine
and Hemotherapy
Interdisciplinary journal for transfusion
medicine, hemotherapy, immunohematology,
and clinical hemostasis
a rc h a ble
Se
Med
in Pub
47 | 01 | 20
Transfusion Medicine and Hemotherapy | Vol. 47, No. 01 (pp. 1–102), 2020
Oncology
Transfusion Medicine
and Hemotherapy
Interdisciplinary journal for transfusion
medicine, hemotherapy, immunohematology,
and clinical hemostasis
Geplante Themenschwerpunkte 2020
Transfusion Medicine and Hemotherapy
Karger
RESEARCH
AUSGABE
1/2020 Blood Group Diagnostics, Genetics, Next-Generation Sequencing
Hrsg.: C. Gassner (Zürich)
Erscheinungstermin: Februar 2020
3/2020 Extra-Corporeal Phototherapy
Hrsg.: A. Buser (Basel), N. Worel (Wien)
Erscheinungstermin: Juni 2020
4/2020 Patient Blood Management
Hrsg: P. Schlenke (Graz), J. Meier (Linz)
Erscheinungstermin: August 2020
5/2020 Tissue Banking
Hrsg: A. Pruß, J. Schroeter (Berlin)
Erscheinungstermin: Oktober 2020
6/2020 Antigen-Presenting Cells and Vaccination Strategies
Hrsg: B. Eiz-Vesper, H. Schmetzer, (München)
Erscheinungstermin: Dezember 2020
Supplement Abstractband zur 53. Jahrestagung der DGTI, 16.–18.09.2020, Berlin
Erscheinungstermin: 16. September 2020Transfusion Medicine
and Hemotherapy
Founded in 1973 as «Die Infusionstherapie» by H. Reissigl, H. Grobecker, U. Henneberg, K.H. Bäßler
Continued by: H.-D. Viering (1973–1977), A. Grünert (1982–1992), G. Kleinberger (1982–1988),
K. Widhalm (1988–1992), G. Wolfram (1990–1992), J. Eckart (1992–1997), H. Forst (1992–1997),
K. Meßmer (1992–1997), K. Peter (1992–1997), K.H. Usadel (1992–1997), B. Zwißler (1995–1997),
K. Gutensohn (1998–2001), V. Kretschmer (1990–2002), W. Stangel (1992–2005),
W. Dzik (1998–2005), H.G. Klein (1998–2005), W. Sibrowski (2003–2014)
Editor-in-Chief
Peter Schlenke, MD – Department of Blood Group Serology and Transfusion Medicine, Medical
University of Graz, Graz, Austria
Associate Editors
Official Organ of Peter Bugert, PhD – Institute of Transfusion Medicine and Immunology, Medical Faculty Mannheim,
Heidelberg University, Mannheim, Germany
Andreas Buser, PhD – Blutspendezentrum SRK beider Basel, Basel, Switzerland
Jens Dreier, PhD – Institute for Laboratory and Transfusion Medicine, Heart and Diabetes Center
North Rhine-Westphalia, Ruhr University Bochum, Bad Oeynhausen, Germany
Britta Eiz-Vesper, PhD – Institute for Transfusion Medicine, Hannover Medical School, Hanover,
Germany
Beat M. Frey, MD – Blood Transfusion Service Zürich, SRC, Schlieren, Switzerland
Christoph Gassner, PhD – Independent Researcher, Zurich, Switzerland
Hans-Gert Heuft, MD – Institute for Transfusion Medicine and Immune Hemotology with Blood Bank
Diagnostics, University Hospital Magdeburg, Magdeburg, Germany
Andreas Humpe, MD – Department of Anesthesiology, Grosshadern Medical Center of the
Ludwig-Maximilian University, Munich, Germany
Wolfgang Korte, MD – Center for Laboratory Medicine, St. Gallen, Switzerland
Behrouz Mansouri Taleghani, MD – University Clinic of Hematology and Central Hematology
Laboratory, Bern University Hospital, Inselspital, Bern, Switzerland
Axel Pruß, MD – Institute of Transfusion Medicine, Charité – Universitätsmedizin Berlin, Berlin,
Germany
Andreas Sputtek, MD – Medical Laboratory Bremen, Bremen, Germany
Franz F. Wagner, MD – Institute Springe, German Red Cross Blood Service NSTOB, Springe, Germany
Editorial Board Members
Jason Acker, PhD – Department of Laboratory Medicine and Pathology, University of Alberta,
Edmonton, AB, Canada
Tamam Bakchoul, MD – Center for Clinical Transfusion Medicine, University Hospital of Tübingen and
German Red Cross Blood Donation Service Baden-Wuerttemberg-Hessen, Tübingen, Germany
Bita Bakhschai, JSD – Law Office Boltz, Scheller & Colleagues, Speyer, Germany
Gregor Bein, MD – Institute for Clinical Immunology and Transfusion Medicine, Justus Liebig
University, Gießen, Germany
Reinhard Burger, MD – Robert Koch Institute, Berlin, Germany
Jürgen Bux, MD – German Red Cross Blood Donation Service West, Hagen, Germany
Toni Cathomen, PhD – Institute for Transfusion Medicine and Gene Therapy, University of Freiburg,
Freiburg, Germany
(Continued on next page)
Printed in Germany on acid-free and non-aging paper
(ISO 9706) by Printec Offset, medienhaus, Kassel(Continued)
Hermann Eichler, MD – Institute of Clinical Hemostaseology and Transfusion Medicine, Saarland
University Medical Center, Homburg/Saar, Germany
Birgit Gathof, MD – Institute for Transfusion Medicine, University Hospital Cologne, Cologne,
Germany
Holger Hackstein, MD – Institute for Transfusion Medicine and Hemostaseology, University Hospital
Erlangen, Erlangen, German
Reinhard Henschler, PhD –Institute for Transfusion Medicine, University Hospital Leipzig, Leipzig,
Germany
Holger Hennig, MD – Institute of Transfusion Medicine, University Hospital of Schleswig-Holstein,
Lübeck, Germany
Volker Kiefel, MD – Institute for Transfusion Medicine, Rostock University Medical School, Rostock,
Germany
Harald Klüter, MD – Institute of Transfusion Medicine and Immunology, Medical Faculty Mannheim,
University of Heidelberg, Mannheim, Germany
Jens Meier, MD – Department of Anesthesiology and Critical Care Medicine, Kepler University
Hospital, Med Campus III, Linz, Austria
Rainer Moog, MD – German Red Cross Blood Donor Service North-East, Institute Cottbus, Cottbus,
Germany
Andrew D. Mumford, PhD – Bristol CardioVascular, University of Bristol, Bristol, UK
Christoph Niederhauser, PhD – Interregional Blood Transfusion SRC Ltd. Bern, Bern, Switzerland
Ruth Offergeld, MD – Robert Koch Institute, Berlin, Germany
Thierry Peyrard, PhD – National Institute of Blood Transfusion (INTS), Paris, France
Katharina Schallmoser, PhD – Blood Group Serology and Transfusion Medicine, Paracelsus Medical
University (PMU) Salzburg, Salzburg, Austria
Rainer Seitz, MD – Paul Ehrlich Institute, Federal Institute for Vaccines and Biomedicines, Langen,
Germany
Donat R. Spahn, MD – Institute of Anesthesiology, University and University Hospital Zurich, Zurich,
Switzerland
Erwin Strasser, MD – Department of Transfusion Medicine & Haemostaseology, University Hospital
Erlangen, Erlangen, Germany
Thomas Thiele, MD – Institute of Immunology and Transfusion Medicine, Department of Transfusion
Medicine, University Medical Center Greifswald, Greifswald, Germany
Jean-Daniel Tissot, MD – Interregional Blood Transfusion, Lausanne, Switzerland
Torsten Tonn, MD – Institute for Transfusion Medicine Dresden, German Red Cross Blood Donation
Service North/East, Medical Faculty Carl Gustav Carus, TU Dresden, Dresden, Germany
Pieter F. van der Meer, PhD – Department of Product and Process Development, Sanquin Blood Bank,
Amsterdam, The Netherlands
Nina Worel, MD – Department for Blood Group Serology and Transfusion Medicine, Medical
University of Vienna, Vienna, Austria
Patrick Wuchter, PhD – Institute of Transfusion Medicine and Immunology, Medical Faculty
Mannheim, University of Heidelberg, Mannheim, Germany
Mark H. Yazer, MD – Department of Pathology, University of Pittsburgh School of Medicine,
Pittsburgh, PA, USA
© 2020 S. Karger AG, Basel
www.karger.com
karger@karger.comVol. 47, No. 2, 2020
Contents
Research Article
103 Human Brucellosis: Risks and Prevalence among Iranian Blood Donors
Residing in Endemic Areas
Zadsar, M.; Shirzadi, M.R.; Zeynali, M.; Rasouli, M.; Karimi, G. (Tehran)
110 Effects and Mechanisms of Vitamin C Post-Conditioning on Platelet
Activation after Hypoxia/Reoxygenation
Liu, D.; Pei, D.; Hu, H.; Gu, G.; Cui, W. (Shijiazhuang)
119 The Sting of Rejection: Deferring Blood Donors due to Low Hemoglobin
Values Reduces Future Returns
Bruhin, A. (Lausanne); Goette, L. (Bonn/Singapore); Haenni, S. (Zurich); Jiang, L.
(Colchester); Markovic, A.; Roethlisberger, A.; Buchli, R.; Frey, B.M. (Schlieren)
129 Rhesus D Antigenic Determinants on Residual Red Blood Cells in Apheresis
and Buffy Coat Platelet Concentrates
Thibault, L.; de Grandmont, M.J.; Cayer, M.-P.; Dussault, N.; Jacques, A.; Ducas, E.;
Beauséjour, A. (Québec, QC); Lebrun, A. (Montréal, QC)
135 Thromboelastography Detects Possible Coagulation Disturbance in
Pediatric Patients with Portal Cavernoma
Wu, L.; Zhang, G.; Guo, C. (Chongqing)
144 Validation of Microbiological Testing of Cellular Medicinal Products
Containing Antibiotics
Lotfi, R.; Rojewski, M.T. (Ulm); Zeplin, P.H. (Ludwigsburg); Funk, W. (Munich);
Pullig, O. (Würzburg); Nöth, U. (Berlin/Würzburg); Schrezenmeier, H. (Ulm)
152 Pathophysiology of Alloimmunization
Molina-Aguilar, R.; Gómez-Ruiz, S.; Vela-Ojeda, J.; Montiel-Cervantes, L.A.; Reyes-
Maldonado, E. (Mexico City)
© 2020 S. Karger AG, Basel
www.karger.com
karger@karger.com160 Molecular Basis of ABO Variants Including Identification of 16 Novel ABO
Subgroup Alleles in Chinese Han Population
Ying, Y.; Hong, X.; Xu, X.; Chen, S.; He, J.; Zhu, F.; Xie, X. (Hangzhou)
167 Comparison of Two Different Fibrinogen Concentrates in an in vitro Model
of Dilutional Coagulopathy
Groene, P.; Wiederkehr, T. (Munich); Kammerer, T. (Munich/Bad Oeynhausen);
Möhnle, P.; Maerte, M.; Bayer, A.; Görlinger, K.; Rehm, M.; Schäfer, S.T. (Munich)
Review Article
175 Beyond Description: The Predictive Role of Affect, Memory, and Context
in the Decision to Donate or Not Donate Blood
Masser, B. (St. Lucia, QLD/Kelvin Grove, QLD); Ferguson, E. (Nottingham);
Merz, E.-M. (Amsterdam); Williams, L. (Sydney, NSW)
Case Report
186 Deletion in the A4GALT Gene Associated with Rare “P null” Phenotype:
The First Report from India
Shastry, S.; Satyamoorthy, K.; Acharya, K.V.; Reddy, V.R.; Mohan, G.; Deepika, C.;
Reghunathan, D.; Joshi, M.B. (Manipal)
Forum
190 Emicizumab: Hoher Blutungschutz in der Routineprophylaxe
193 News
© 2020 S. Karger AG, Basel
www.karger.com
karger@karger.comJAHRESTAGUNG
Jahrestagung der Deutschen, Österreichischen
und Schweizerischen Gesellschaften für
Hämatologie und Medizinische Onkologie
www.haematologie-onkologie-2020.com
Call for Abstracts Abstracteinreichung bis 4. Mai 2020
unter www.haematologie-onkologie-2020.com
Wir laden Sie herzlich ein, Ihre aktuellen wissenschaftlichen Beiträge und Forschungsergebnisse einzureichen.
Angenommene Abstracts werden als Vorträge oder Posterpräsentationen in das Programm aufgenommen.
HÄMATOLOGIE
• Akute lymphatische Leukämie • Hodgkin-Lymphom • Multiples Myelom und andere Plasmazellerkrankungen
• Akute myeloische Leukämie • Chronische lymphatische Leukämie • Myelodysplastische Syndrome
• B-Zell-Lymphome, aggressiv • Chronische myeloische Leukämie • Nichtmaligne Hämatologie (exkl. Anämien)
• B-Zell-Lymphome, indolent • Chronische myeloproliferative Neoplasien • Nichtmaligne Hämatologie: Anämien,
• Sonstige B-Zell-Lymphome • Gerinnung und Thrombozyten Eisenstoffwechsel
• T-Zell-Lymphome • Hämatopoetische Stammzellen • Sonstige Hämatologie
ONKOLOGIE
• Gynäkologische Malignome (z. B. Ovar, • Magenkarzinom (inkl. Kardia) • Prostatakarzinom
Uterus; exkl. Mammakarzinom) • Mammakarzinom • Sarkome
• Hepatobiliäres Karzinom • Melanom und andere Hauttumoren • Urogenitale Tumoren (z. B. Blase,
• Keimzelltumoren • Neuroendokrine und Endokrine Tumoren NEU exkl. Prostatakarzinom)
• Kolon-/ Rektumkarzinom • Nierenzellkarzinom • ZNS-Tumoren
• Kopf-Hals-Tumoren • Ösophaguskarzinom • Sonstige Onkologie
• Lungenkarzinom (inkl. Pleura) • Pankreaskarzinom
QUERSCHNITTSTHEMEN
• Adoleszente und junge Erwachsene (AYA) • Palliativmedizin • Translationale Forschung und neue Substanzen
• Der spezielle Fall • Patientensicherheit • Tumor-/ Zellbiologie
• Diagnose und Therapie der Infektion • Pflege • Versorgungsforschung
• Ethik • Prävention/Epidemiologie • Blutstammzelltransplantation und zelluläre Therapien
• Geriatrische Onkologie • Psychoonkologie • Big Data und Digitale Medizin
• Immuntherapie • Rehabilitation • Studentische Lehre in der Hämatologie und Onkologie
• Intensivmedizin, Notfälle • Diagnose und Therapie der Infektionen • Weiterbildungskonzepte in der Hämatologie und
• Komplementärmedizin • Supportive Therapie (z. B. Antiemetika, Onkologie
• Langzeitüberlebende exkl. Infektionen) • Sonstige Themen
KONGRESSORT: Congress Center Basel · Messeplatz 21 · 4058 Basel · Schweiz
KONGRESSPRÄSIDENT: Prof. Dr. med. Markus G. Manz, Universitätsspital Zürich
F20059
KONGRESSORGANISATION: DGHO Service GmbH · Alexanderplatz 1 · 10178 Berlin · jahrestagung2020@dgho-service.deJournal Information
Aims and Scope
This journal is devoted to all areas of transfusion medicine. These include the quality and
security of blood products, therapy with blood components and plasma derivatives, trans-
fusion-related questions in transplantation, stem cell manipulation, therapeutic and diag-
nostic problems of hemostasis, immuno-hematological investigations, and legal aspects of
the production of blood products as well as hemotherapy. Both comprehensive reviews and
Guidelines for Authors primary publications that detail the newest work in transfusion medicine and hemotherapy
We strongly encourage authors to read
the Guidelines for Authors at
promote the international exchange of knowledge within these disciplines. Consistent with
www.karger.com/tmh_guidelines prior to this goal, continuing clinical education is also specifically addressed.
submitting an article.
Journal Contact
For questions or comments, please contact
the persons responsible who can be found at
http://www.karger.com/Journal/Contact/224170.
ISSN Print Edition: 1660–3796 Subscription Orders: Subscription Rates: Subscriptions run for a full
ISSN Online Edition: 1660–3818 Orders can be placed at agencies, bookstores, calendar year. Prices are given per year.
or directly with the Publisher.
Journal Homepage: www.karger.com/tmh Personal subscription:
Bibliographic Indices: This journal is regularly list- S. Karger Verlag für Medizin und
Print or Online Print+Online combined
ed in bibliographic services, including PubMed/ Naturwissenschaften GmbH
CHF 250.00 CHF 375.00
PubMed Central, Web of Science, Google Scholar, Schnewlinstrasse 12
EUR 230.00 EUR 345.00
Scopus Embase. 79098 Freiburg (Germany)
USD 250.00 USD 375.00
Publication Data: Transfusion Medicine and Therapy S. Karger AG postage and handling
is published 6 times a year. Volume 47 with 6 issues Medical and Scientific Publishers (added to print and print+online)
appears in 2020. Allschwilerstrasse 10 CHF 66.00 Europe, CHF 93.00 Overseas
CH–4009 Basel EUR 24.00
Copyright: © 2020 S. Karger AG, Basel (Switzerland). Switzerland USD 90.00
All rights reserved. No part of this publication may be
t: +41 61 306 11 11
translated into other languages, reproduced or uti- Institutional subscription:
f: +41 61 306 12 34
lized in any form or by any means, electronic or me-
e: karger@karger.com Print or Online Print+Online combined
chanical, including photocopying, recording, micro-
w: www.karger.com CHF 250.00 CHF 375.00
copying, or by any information storage and retrieval
EUR 230.00 EUR 345.00
system, without permission in writing from the pub- (for courier services only:
USD 250.00 USD 375.00
lisher. Allschwilerstrasse 10
CH–4055 Basel) postage and handling
Disclaimer: The statements, opinions and data con- (added to print and print+online)
tained in this publication are solely those of the indi- Change of Address: CHF 66.00 Europe, CHF 93.00 Overseas
vidual authors and contributors and not of the pub- Both old and new addresses should be sent EUR 24.00
lisher and the editor(s). The appearance of advertise- to the subscription source. USD 90.00
ments in the journal is not a warranty, endorsement,
or approval of the products or services advertised or Advertising: Correspondence should be addressed Discount subscription prices: Please enquire about
of their effectiveness, quality or safety. The publisher to the publisher. reduced rates for members of related societies.
and the editor(s) disclaim responsibility for any injury S. Karger Verlag für Medizin und
to persons or property resulting from any ideas, Naturwissenschaften GmbH Back Volumes and Single Issues: Information on
methods, instructions or products referred to in the Attn. Ellen Zimmermann (Corporate Sales Manager) availability and prices of single print issues and print
content or advertisements. e.zimmermann@karger.com or electronic back volumes can be obtained from
Price list No. 34 of January, 1, 2020 is effective. Customer Service at service@karger.com.
© 2020 S. Karger AG, Basel
www.karger.com
karger@karger.comA single source for international hematology research and
clinical practice since 1948
Editor-in-Chief Associate Editor
P. Raanani, U. Nowak-Göttl,
Petah Tikva Kiel
Acta Haematologica is a well-established and internationally recognized Selected contributions
clinically-oriented journal with a prominent Editorial Board featuring • Are the Polyomaviruses BK and JC Associated with Opportunistic
balanced, wide-ranging coverage of current hematology research. It Infections, Graft-versus-Host Disease, or Worse Outcomes in Adult
contains a wealth of information on such problems as anemia, blood Patients Receiving Their First Allogeneic Stem Cell Transplantation with
coagulation abnormalities, acute and chronic leukemias, Hodgkin and Low-Dose Alemtuzumab?: Schneidewind, L. (Homburg/Saar); Neumann, T.;
Knoll, F.; Zimmermann, K. (Greifswald); Smola, S. (Homburg/Saar); Schmidt, C.A.;
non-Hodgkin lymphomas, multiple myeloma and paraproteinemias as
Krüger, W. (Greifswald)
well as rare and hereditary hematological disorders. The journal features • A Novel PCM1-PDGFRB Fusion in a Patient with a Chronic Myeloprolifera-
first-rate basic and clinical original papers, some of which are accom- tive Neoplasm and an ins(8;5): Ghazzawi, M. (Southampton/Salisbury);
panied by editorial commentaries by eminent experts. These original Mehra, V. (London); Knut, M. (Southampton); Brown, L. (London); Tapper, W.
articles are supplemented by short state-of-the-art communications, (Southampton); Chase, A. (Southampton/Salisbury); de Lavallade, H. (London);
reviews and correspondence as well as case reports and meta-analyses. Cross, N.C.P. (Southampton/Salisbury)
The journal has been and will always be committed to bring to its read- • Molecular Genetic Mechanisms of Hereditary Spherocytosis:
ers cutting edge clinical information, including the different aspects of Current Perspectives: He, B.-J.; Liao, L.; Deng, Z.-F.; Tao, Y.-F.; Xu, Y.-C.;
hematology, alongside translational research relevant to clinical daily Lin, F.-Q. (Nanning)
life, thus keeping the practicing hematologist well informed of the new • Clinical Course and Outcome of Childhood Acquired Platelet
Dysfunction with Eosinophilia: Chotsampancharoen, T.; Sripornsawan, P.;
developments in the field of benign as well as malignant hematology. Duangchu, S.; McNeil, E. (Hat Yai)
Acta Haematologica • Incidence, Survival, and Risk Factors for Adults with Acute Myeloid
Founded: 1948 Leukemia Not Otherwise Specified and Acute Myeloid Leukemia with
Category: Clinical and Basic Research Recurrent Genetic Abnormalities: Analysis of the Surveillance,
Field of Interest: Hematology Epidemiology, and End Results (SEER) Database, 2001–2013: Song, X.;
Peng, Y.; Wang, X.; Chen, Y.; Jin, L.; Yang, T.; Qian, M.; Ni, W.; Tong, X.; Lan, J.
Listed in bibliographic services, including: (Hangzhou)
PubMed/MEDLINE, Web of Science, Google Scholar, • Routine Screening for KIT M541L Is Not Warranted in the Diagnostic
Scopus, Embase Work-Up of Patients with Hypereosinophilia: Hoade, Y. (Salisbury/
Southampton); Metzgeroth, G.; Schwaab, J.; Reiter A.; (Mannheim/Heidelberg);
2019: Volumes 141, 142 Cross N.C.P., A.; Cross, N.C.P. (Salisbury/Southampton)
4 issues per volume • Review of Rosai-Dorfman Disease: New Insights into the Pathogenesis of
Language: English This Rare Disorder: Cai, Y.; Shi, Z.; Bai, Y. (Changchun)
ISSN 0001–5792 • The Complexities of Defining a Complex Karyotype in Hematological
e-ISSN 1421–9662 Malignancies: A Need for Standardization?: Peterson, J.F. (Milwaukee, WI)
KF19002
Impact Factor: 1.307
More information at w w w. karger.com/ahaSie können auch lesen
